EMEA guidance on QOL assessment inadequate

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.310, 2001-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Health-Related Quality of Life (HR-QOL) and Regulatory Issues: An Assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) Recommendations on the Use of HR-QOL Measures in Drug Approval

By Apolone G.  

PharmacoEconomics, Vol. 19, Iss. 2, 2001-01 ,pp. : 187-195

Adis International

Access to resources Recommend Favorite

EMEA provide guidance on gadolinium contrast agents

By  

Reactions Weekly, Vol. 1, Iss. 1280, 2009-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

QOL assessment tailored to patients with schizophrenia

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 277, 2000-01 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite

EMEA recommends veralipride withdrawal

By  

Reactions Weekly, Vol. 1, Iss. 1162, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

EMEA recommends suspending Acomplia

By  

Reactions Weekly, Vol. 1, Iss. 1226, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite